324 related articles for article (PubMed ID: 12707390)
1. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
2. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice.
Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR
Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264
[TBL] [Abstract][Full Text] [Related]
3. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
[TBL] [Abstract][Full Text] [Related]
5. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein.
Yao J; Le TC; Kos CH; Henderson JM; Allen PG; Denker BM; Pollak MR
PLoS Biol; 2004 Jun; 2(6):e167. PubMed ID: 15208719
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
[TBL] [Abstract][Full Text] [Related]
7. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch.
Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953
[TBL] [Abstract][Full Text] [Related]
8. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.
Kaplan JM; Kim SH; North KN; Rennke H; Correia LA; Tong HQ; Mathis BJ; Rodríguez-Pérez JC; Allen PG; Beggs AH; Pollak MR
Nat Genet; 2000 Mar; 24(3):251-6. PubMed ID: 10700177
[TBL] [Abstract][Full Text] [Related]
9. Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGS.
Bartram MP; Habbig S; Pahmeyer C; Höhne M; Weber LT; Thiele H; Altmüller J; Kottoor N; Wenzel A; Krueger M; Schermer B; Benzing T; Rinschen MM; Beck BB
Hum Mol Genet; 2016 Mar; 25(6):1152-64. PubMed ID: 26740551
[TBL] [Abstract][Full Text] [Related]
10. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.
Henderson JM; Alexander MP; Pollak MR
J Am Soc Nephrol; 2009 May; 20(5):961-8. PubMed ID: 19357256
[TBL] [Abstract][Full Text] [Related]
11. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.
Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY
J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations in alpha-actinin 4 and podocin genes of patients with chronic renal failure due to sporadic focal segmental glomerulosclerosis.
Komatsuda A; Wakui H; Maki N; Kigawa A; Goto H; Ohtani H; Hamai K; Oyama Y; Makoto H; Sawada K; Imai H
Ren Fail; 2003 Jan; 25(1):87-93. PubMed ID: 12617336
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis ACTN4 mutants binding to actin: regulation by phosphomimetic mutations.
Shao H; Wingert B; Weins A; Pollak MR; Camacho C; Wells A
Sci Rep; 2019 Oct; 9(1):15517. PubMed ID: 31664084
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis.
Dai S; Wang Z; Pan X; Wang W; Chen X; Ren H; Hao C; Han B; Chen N
Nephrol Dial Transplant; 2010 Mar; 25(3):824-35. PubMed ID: 19666657
[TBL] [Abstract][Full Text] [Related]
15. Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis.
Weins A; Kenlan P; Herbert S; Le TC; Villegas I; Kaplan BS; Appel GB; Pollak MR
J Am Soc Nephrol; 2005 Dec; 16(12):3694-701. PubMed ID: 16251236
[TBL] [Abstract][Full Text] [Related]
16. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
17. [A genetic viewpoint of focal glomerular sclerosis: fom genes to glomerular pathophysiology [corrected]].
Aucella F; Bisceglia L; Stallone C
G Ital Nefrol; 2003; 20(4):356-67. PubMed ID: 14523896
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.
Schmid H; Henger A; Cohen CD; Frach K; Gröne HJ; Schlöndorff D; Kretzler M
J Am Soc Nephrol; 2003 Nov; 14(11):2958-66. PubMed ID: 14569107
[TBL] [Abstract][Full Text] [Related]
19. Proteostasis as a therapeutic target in glomerular injury associated with mutant α-actinin-4.
Yee A; Papillon J; Guillemette J; Kaufman DR; Kennedy CRJ; Cybulsky AV
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F954-F966. PubMed ID: 29873512
[TBL] [Abstract][Full Text] [Related]
20. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
